ScholarIQanswers from OpenAlex

The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders

PaperCitations, authors & open-access status

The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders have?

ScholarIQcitation count

The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders has 145 citations in the OpenAlex counts ScholarIQ stores.

When was The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders published?

ScholarIQyear

The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders has 2020 year in the ScholarIQ index.

What is the open-access status of The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders?

ScholarIQoa status

The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders has gold oa status in the ScholarIQ index.

What is the DOI of The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders?

ScholarIQdoi

The DOI for The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders is on the source record.

What is the PMID of The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders?

ScholarIQpmid

The PMID for The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders is on the source record.

What is the OpenAlex record for The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders?

ScholarIQopenalex

The OpenAlex for The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial